Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, Big Data Institute, University of Oxford, Oxford, UK
Max Planck Institute for Demographic Research, Rostock, Germany.
BMJ. 2021 Nov 3;375:e066768. doi: 10.1136/bmj-2021-066768.
To estimate the changes in life expectancy and years of life lost in 2020 associated with the covid-19 pandemic.
Time series analysis.
37 upper-middle and high income countries or regions with reliable and complete mortality data.
Annual all cause mortality data from the Human Mortality Database for 2005-20, harmonised and disaggregated by age and sex.
Reduction in life expectancy was estimated as the difference between observed and expected life expectancy in 2020 using the Lee-Carter model. Excess years of life lost were estimated as the difference between the observed and expected years of life lost in 2020 using the World Health Organization standard life table.
Reduction in life expectancy in men and women was observed in all the countries studied except New Zealand, Taiwan, and Norway, where there was a gain in life expectancy in 2020. No evidence was found of a change in life expectancy in Denmark, Iceland, and South Korea. The highest reduction in life expectancy was observed in Russia (men: -2.33, 95% confidence interval -2.50 to -2.17; women: -2.14, -2.25 to -2.03), the United States (men: -2.27, -2.39 to -2.15; women: -1.61, -1.70 to -1.51), Bulgaria (men: -1.96, -2.11 to -1.81; women: -1.37, -1.74 to -1.01), Lithuania (men: -1.83, -2.07 to -1.59; women: -1.21, -1.36 to -1.05), Chile (men: -1.64, -1.97 to -1.32; women: -0.88, -1.28 to -0.50), and Spain (men: -1.35, -1.53 to -1.18; women: -1.13, -1.37 to -0.90). Years of life lost in 2020 were higher than expected in all countries except Taiwan, New Zealand, Norway, Iceland, Denmark, and South Korea. In the remaining 31 countries, more than 222 million years of life were lost in 2020, which is 28.1 million (95% confidence interval 26.8m to 29.5m) years of life lost more than expected (17.3 million (16.8m to 17.8m) in men and 10.8 million (10.4m to 11.3m) in women). The highest excess years of life lost per 100 000 population were observed in Bulgaria (men: 7260, 95% confidence interval 6820 to 7710; women: 3730, 2740 to 4730), Russia (men: 7020, 6550 to 7480; women: 4760, 4530 to 4990), Lithuania (men: 5430, 4750 to 6070; women: 2640, 2310 to 2980), the US (men: 4350, 4170 to 4530; women: 2430, 2320 to 2550), Poland (men: 3830, 3540 to 4120; women: 1830, 1630 to 2040), and Hungary (men: 2770, 2490 to 3040; women: 1920, 1590 to 2240). The excess years of life lost were relatively low in people younger than 65 years, except in Russia, Bulgaria, Lithuania, and the US where the excess years of life lost was >2000 per 100 000.
More than 28 million excess years of life were lost in 2020 in 31 countries, with a higher rate in men than women. Excess years of life lost associated with the covid-19 pandemic in 2020 were more than five times higher than those associated with the seasonal influenza epidemic in 2015.
估计 2020 年与 COVID-19 大流行相关的男性和女性预期寿命变化以及损失的寿命年数。
时间序列分析。
37 个具有可靠和完整死亡率数据的中高收入国家或地区。
2005-20 年人类死亡率数据库的年度全因死亡率数据,按年龄和性别进行协调和细分。
使用 Lee-Carter 模型估计 2020 年观察到的和预期的预期寿命之间的预期寿命减少。使用世界卫生组织标准生命表估计 2020 年观察到的和预期的损失寿命年数之间的超额寿命年数。
除新西兰、中国台湾和挪威外,所有研究国家的男性和女性预期寿命均有所下降,这些国家在 2020 年的预期寿命有所增加。在丹麦、冰岛和韩国没有发现预期寿命变化的证据。预期寿命下降幅度最大的国家是俄罗斯(男性:-2.33,95%置信区间-2.50 至-2.17;女性:-2.14,-2.25 至-2.03)、美国(男性:-2.27,-2.39 至-2.15;女性:-1.61,-1.70 至-1.51)、保加利亚(男性:-1.96,-2.11 至-1.81;女性:-1.37,-1.74 至-1.01)、立陶宛(男性:-1.83,-2.07 至-1.59;女性:-1.21,-1.36 至-1.05)、智利(男性:-1.64,-1.97 至-1.32;女性:-0.88,-1.28 至-0.50)和西班牙(男性:-1.35,-1.53 至-1.18;女性:-1.13,-1.37 至-1.09)。除中国台湾、新西兰、挪威、冰岛、丹麦和韩国外,所有国家的 2020 年损失寿命年数均高于预期。在其余 31 个国家中,2020 年损失了超过 2.22 亿年的生命,比预期多损失了 2810 万年(95%置信区间 2680 万至 2950 万)(男性 1730 万(1680 万至 1780 万),女性 1080 万(1040 万至 1130 万))。每 10 万人中损失的超额寿命年数最高的国家是保加利亚(男性:7260,95%置信区间 6820 至 7710;女性:3730,2740 至 4730)、俄罗斯(男性:7020,6550 至 7480;女性:4760,4530 至 4990)、立陶宛(男性:5430,4750 至 6070;女性:2640,2310 至 2980)、美国(男性:4350,4170 至 4530;女性:2430,2320 至 2550)、波兰(男性:3830,3540 至 4120;女性:1830,1630 至 2040)和匈牙利(男性:2770,2490 至 3040;女性:1920,1590 至 2240)。65 岁以下人群的超额寿命损失相对较低,除俄罗斯、保加利亚、立陶宛和美国外,这些国家的超额寿命损失超过 2000 年/10 万人。
在 31 个国家中,2020 年有超过 2800 万人的寿命损失,男性的损失率高于女性。与 2020 年 COVID-19 大流行相关的超额寿命损失是 2015 年季节性流感流行的五倍多。